Listed

UNITED THERAPEUTICS Corp

UTHRNasdaqCIK 1082554HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$783.3m, Q2 FY2026
Operating income$330.8m, Q2 FY2026
Net income$333.0m, Q2 FY2026
UNITED THERAPEUTICS Corp, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m609Revenue, Q3 FY2023, three months to 2023-09-30$609.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-10-30, accession 0001082554-24-000047.Report this figure615Revenue, Q4 FY2023, three months to 2023-12-31$614.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure678Revenue, Q1 FY2024, three months to 2024-03-31$677.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure715Revenue, Q2 FY2024, three months to 2024-06-30$714.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure749Revenue, Q3 FY2024, three months to 2024-09-30$748.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure736Revenue, Q4 FY2024, three months to 2024-12-31$735.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure794Revenue, Q1 FY2025, three months to 2025-03-31$794.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure799Revenue, Q2 FY2025, three months to 2025-06-30$798.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure800Revenue, Q3 FY2025, three months to 2025-09-30$799.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure790Revenue, Q4 FY2025, three months to 2025-12-31$790.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure782Revenue, Q1 FY2026, three months to 2026-03-31$781.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure783Revenue, Q2 FY2026, three months to 2026-06-30$783.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure
Cost of revenue$m70.1Cost of revenue, Q3 FY2023, three months to 2023-09-30$70.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-10-30, accession 0001082554-24-000047.Report this figure71.0Cost of revenue, Q4 FY2023, three months to 2023-12-31$71.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure72.9Cost of revenue, Q1 FY2024, three months to 2024-03-31$72.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure77.8Cost of revenue, Q2 FY2024, three months to 2024-06-30$77.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure83.1Cost of revenue, Q3 FY2024, three months to 2024-09-30$83.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure75.9Cost of revenue, Q4 FY2024, three months to 2024-12-31$75.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure92.5Cost of revenue, Q1 FY2025, three months to 2025-03-31$92.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure87.6Cost of revenue, Q2 FY2025, three months to 2025-06-30$87.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure101Cost of revenue, Q3 FY2025, three months to 2025-09-30$100.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure103Cost of revenue, Q4 FY2025, three months to 2025-12-31$103.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure133Cost of revenue, Q1 FY2026, three months to 2026-03-31$133.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure99.5Cost of revenue, Q2 FY2026, three months to 2026-06-30$99.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure
Gross profit$m539Gross profit, Q3 FY2023, three months to 2023-09-30$539.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-10-30, accession 0001082554-24-000047.Report this figure544Gross profit, Q4 FY2023, three months to 2023-12-31$543.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure605Gross profit, Q1 FY2024, three months to 2024-03-31$604.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure637Gross profit, Q2 FY2024, three months to 2024-06-30$637.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure666Gross profit, Q3 FY2024, three months to 2024-09-30$665.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure660Gross profit, Q4 FY2024, three months to 2024-12-31$660.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure702Gross profit, Q1 FY2025, three months to 2025-03-31$701.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure711Gross profit, Q2 FY2025, three months to 2025-06-30$711.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure699Gross profit, Q3 FY2025, three months to 2025-09-30$698.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure687Gross profit, Q4 FY2025, three months to 2025-12-31$686.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure648Gross profit, Q1 FY2026, three months to 2026-03-31$648.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure684Gross profit, Q2 FY2026, three months to 2026-06-30$683.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure
Research and development$m84.7Research and development, Q3 FY2023, three months to 2023-09-30$84.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-10-30, accession 0001082554-24-000047.Report this figure151Research and development, Q4 FY2023, three months to 2023-12-31$151.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure104Research and development, Q1 FY2024, three months to 2024-03-31$104.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure140Research and development, Q2 FY2024, three months to 2024-06-30$139.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure104Research and development, Q3 FY2024, three months to 2024-09-30$103.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure134Research and development, Q4 FY2024, three months to 2024-12-31$133.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure149Research and development, Q1 FY2025, three months to 2025-03-31$149.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure134Research and development, Q2 FY2025, three months to 2025-06-30$134.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure128Research and development, Q3 FY2025, three months to 2025-09-30$127.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure140Research and development, Q4 FY2025, three months to 2025-12-31$139.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure138Research and development, Q1 FY2026, three months to 2026-03-31$138.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure146Research and development, Q2 FY2026, three months to 2026-06-30$146.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure
Selling, general and administrative$m128Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$127.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-10-30, accession 0001082554-24-000047.Report this figure132Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$132.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure144Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$144.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure178Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$177.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure219Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$219.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure169Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$168.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure170Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$170.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure213Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$212.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure183Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$182.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure191Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$190.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure184Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$184.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure207Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$206.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure
Operating income$m327Operating income, Q3 FY2023, three months to 2023-09-30$327.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-10-30, accession 0001082554-24-000047.Report this figure260Operating income, Q4 FY2023, three months to 2023-12-31$260.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure356Operating income, Q1 FY2024, three months to 2024-03-31$356.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure320Operating income, Q2 FY2024, three months to 2024-06-30$319.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure343Operating income, Q3 FY2024, three months to 2024-09-30$343.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure358Operating income, Q4 FY2024, three months to 2024-12-31$357.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure383Operating income, Q1 FY2025, three months to 2025-03-31$382.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure365Operating income, Q2 FY2025, three months to 2025-06-30$364.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure389Operating income, Q3 FY2025, three months to 2025-09-30$388.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure357Operating income, Q4 FY2025, three months to 2025-12-31$356.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure326Operating income, Q1 FY2026, three months to 2026-03-31$325.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure331Operating income, Q2 FY2026, three months to 2026-06-30$330.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure
Interest expense$m15.6Interest expense, Q3 FY2023, three months to 2023-09-30$15.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-01, accession 0001082554-23-000031.Report this figure15.1Interest expense, Q4 FY2023, three months to 2023-12-31$15.1m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-21, accession 0001082554-24-000005. Derived: 12-month figure less the 9-month figure.Report this figure13.3Interest expense, Q1 FY2024, three months to 2024-03-31$13.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-01, accession 0001082554-24-000025.Report this figure11.6Interest expense, Q2 FY2024, three months to 2024-06-30$11.6m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure10.1Interest expense, Q3 FY2024, three months to 2024-09-30$10.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure7.9Interest expense, Q4 FY2024, three months to 2024-12-31$7.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure6.1Interest expense, Q1 FY2025, three months to 2025-03-31$6.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure7.3Interest expense, Q2 FY2025, three months to 2025-06-30$7.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure3.0Interest expense, Q3 FY2025, three months to 2025-09-30$3.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure3.1Interest expense, Q4 FY2025, three months to 2025-12-31$3.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure3.0Interest expense, Q1 FY2026, three months to 2026-03-31$3.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure2.9Interest expense, Q2 FY2026, three months to 2026-06-30$2.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure
Income tax$m84.2Income tax, Q3 FY2023, three months to 2023-09-30$84.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-10-30, accession 0001082554-24-000047.Report this figure78.3Income tax, Q4 FY2023, three months to 2023-12-31$78.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure92.0Income tax, Q1 FY2024, three months to 2024-03-31$92.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure77.2Income tax, Q2 FY2024, three months to 2024-06-30$77.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure79.5Income tax, Q3 FY2024, three months to 2024-09-30$79.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure95.2Income tax, Q4 FY2024, three months to 2024-12-31$95.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure101Income tax, Q1 FY2025, three months to 2025-03-31$101.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure98.9Income tax, Q2 FY2025, three months to 2025-06-30$98.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure99.3Income tax, Q3 FY2025, three months to 2025-09-30$99.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure79.7Income tax, Q4 FY2025, three months to 2025-12-31$79.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure43.4Income tax, Q1 FY2026, three months to 2026-03-31$43.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure39.7Income tax, Q2 FY2026, three months to 2026-06-30$39.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure
Net income$m268Net income, Q3 FY2023, three months to 2023-09-30$267.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-30, accession 0001082554-24-000047.Report this figure217Net income, Q4 FY2023, three months to 2023-12-31$217.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure307Net income, Q1 FY2024, three months to 2024-03-31$306.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure278Net income, Q2 FY2024, three months to 2024-06-30$278.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure309Net income, Q3 FY2024, three months to 2024-09-30$309.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure301Net income, Q4 FY2024, three months to 2024-12-31$301.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure322Net income, Q1 FY2025, three months to 2025-03-31$322.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure310Net income, Q2 FY2025, three months to 2025-06-30$309.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure339Net income, Q3 FY2025, three months to 2025-09-30$338.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure364Net income, Q4 FY2025, three months to 2025-12-31$364.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure275Net income, Q1 FY2026, three months to 2026-03-31$274.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure333Net income, Q2 FY2026, three months to 2026-06-30$333.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure
Diluted EPS$ per share5.38Diluted EPS, Q3 FY2023, three months to 2023-09-30$5.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-30, accession 0001082554-24-000047.Report this figurenot reported6.17Diluted EPS, Q1 FY2024, three months to 2024-03-31$6.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure5.85Diluted EPS, Q2 FY2024, three months to 2024-06-30$5.85 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure6.39Diluted EPS, Q3 FY2024, three months to 2024-09-30$6.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figurenot reported6.63Diluted EPS, Q1 FY2025, three months to 2025-03-31$6.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure6.41Diluted EPS, Q2 FY2025, three months to 2025-06-30$6.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure7.16Diluted EPS, Q3 FY2025, three months to 2025-09-30$7.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figurenot reported5.82Diluted EPS, Q1 FY2026, three months to 2026-03-31$5.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure7.27Diluted EPS, Q2 FY2026, three months to 2026-06-30$7.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure
Basic EPS$ per share5.71Basic EPS, Q3 FY2023, three months to 2023-09-30$5.71 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-30, accession 0001082554-24-000047.Report this figurenot reported6.52Basic EPS, Q1 FY2024, three months to 2024-03-31$6.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure6.26Basic EPS, Q2 FY2024, three months to 2024-06-30$6.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure6.93Basic EPS, Q3 FY2024, three months to 2024-09-30$6.93 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figurenot reported7.18Basic EPS, Q1 FY2025, three months to 2025-03-31$7.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure6.86Basic EPS, Q2 FY2025, three months to 2025-06-30$6.86 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure7.73Basic EPS, Q3 FY2025, three months to 2025-09-30$7.73 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figurenot reported6.32Basic EPS, Q1 FY2026, three months to 2026-03-31$6.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure7.82Basic EPS, Q2 FY2026, three months to 2026-06-30$7.82 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure

Balance sheet

Cash and equivalents$1.80bn, Q2 FY2026
Shareholders' equity$6.40bn, Q2 FY2026
UNITED THERAPEUTICS Corp, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m1,108Cash and equivalents, Q3 FY2023, at 2023-09-30$1.11bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-01, accession 0001082554-23-000031.Report this figure1,208Cash and equivalents, FY2023, at 2023-12-31$1.21bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-26, accession 0001082554-25-000005.Report this figure1,252Cash and equivalents, Q1 FY2024, at 2024-03-31$1.25bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-01, accession 0001082554-24-000025.Report this figure1,356Cash and equivalents, Q2 FY2024, at 2024-06-30$1.36bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-07-31, accession 0001082554-24-000035.Report this figure1,554Cash and equivalents, Q3 FY2024, at 2024-09-30$1.55bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-30, accession 0001082554-24-000047.Report this figure1,697Cash and equivalents, FY2024, at 2024-12-31$1.70bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-25, accession 0001082554-26-000006.Report this figure1,900Cash and equivalents, Q1 FY2025, at 2025-03-31$1.90bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure1,593Cash and equivalents, Q2 FY2025, at 2025-06-30$1.59bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure1,340Cash and equivalents, Q3 FY2025, at 2025-09-30$1.34bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure1,557Cash and equivalents, FY2025, at 2025-12-31$1.56bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure1,280Cash and equivalents, Q1 FY2026, at 2026-03-31$1.28bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure1,803Cash and equivalents, Q2 FY2026, at 2026-06-30$1.80bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure
Current assets$m3,459Current assets, Q3 FY2023, at 2023-09-30$3.46bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-01, accession 0001082554-23-000031.Report this figure3,551Current assets, FY2023, at 2023-12-31$3.55bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-26, accession 0001082554-25-000005.Report this figure3,249Current assets, Q1 FY2024, at 2024-03-31$3.25bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-01, accession 0001082554-24-000025.Report this figure3,620Current assets, Q2 FY2024, at 2024-06-30$3.62bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-07-31, accession 0001082554-24-000035.Report this figure4,000Current assets, Q3 FY2024, at 2024-09-30$4.00bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-30, accession 0001082554-24-000047.Report this figure3,874Current assets, FY2024, at 2024-12-31$3.87bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-25, accession 0001082554-26-000006.Report this figure3,940Current assets, Q1 FY2025, at 2025-03-31$3.94bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure3,827Current assets, Q2 FY2025, at 2025-06-30$3.83bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure3,494Current assets, Q3 FY2025, at 2025-09-30$3.49bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure3,703Current assets, FY2025, at 2025-12-31$3.70bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure2,872Current assets, Q1 FY2026, at 2026-03-31$2.87bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure3,484Current assets, Q2 FY2026, at 2026-06-30$3.48bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure
Total assets$m7,024Total assets, Q3 FY2023, at 2023-09-30$7.02bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-01, accession 0001082554-23-000031.Report this figure7,167Total assets, FY2023, at 2023-12-31$7.17bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-26, accession 0001082554-25-000005.Report this figure6,495Total assets, Q1 FY2024, at 2024-03-31$6.50bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-01, accession 0001082554-24-000025.Report this figure6,723Total assets, Q2 FY2024, at 2024-06-30$6.72bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-07-31, accession 0001082554-24-000035.Report this figure7,123Total assets, Q3 FY2024, at 2024-09-30$7.12bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-30, accession 0001082554-24-000047.Report this figure7,364Total assets, FY2024, at 2024-12-31$7.36bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-25, accession 0001082554-26-000006.Report this figure7,744Total assets, Q1 FY2025, at 2025-03-31$7.74bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure7,908Total assets, Q2 FY2025, at 2025-06-30$7.91bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure7,351Total assets, Q3 FY2025, at 2025-09-30$7.35bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure7,880Total assets, FY2025, at 2025-12-31$7.88bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure6,714Total assets, Q1 FY2026, at 2026-03-31$6.71bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure7,220Total assets, Q2 FY2026, at 2026-06-30$7.22bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure
Current liabilities$m744Current liabilities, Q3 FY2023, at 2023-09-30$744.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-01, accession 0001082554-23-000031.Report this figure804Current liabilities, FY2023, at 2023-12-31$804.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-26, accession 0001082554-25-000005.Report this figure861Current liabilities, Q1 FY2024, at 2024-03-31$860.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-01, accession 0001082554-24-000025.Report this figure832Current liabilities, Q2 FY2024, at 2024-06-30$832.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-07-31, accession 0001082554-24-000035.Report this figure873Current liabilities, Q3 FY2024, at 2024-09-30$873.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-30, accession 0001082554-24-000047.Report this figure738Current liabilities, FY2024, at 2024-12-31$738.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-25, accession 0001082554-26-000006.Report this figure722Current liabilities, Q1 FY2025, at 2025-03-31$721.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure527Current liabilities, Q2 FY2025, at 2025-06-30$527.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure546Current liabilities, Q3 FY2025, at 2025-09-30$546.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure561Current liabilities, FY2025, at 2025-12-31$560.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure599Current liabilities, Q1 FY2026, at 2026-03-31$599.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure608Current liabilities, Q2 FY2026, at 2026-06-30$607.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure
Total liabilities$m1,312Total liabilities, Q3 FY2023, at 2023-09-30$1.31bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-01, accession 0001082554-23-000031.Report this figure1,182Total liabilities, FY2023, at 2023-12-31$1.18bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-26, accession 0001082554-25-000005.Report this figure1,157Total liabilities, Q1 FY2024, at 2024-03-31$1.16bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-01, accession 0001082554-24-000025.Report this figure1,026Total liabilities, Q2 FY2024, at 2024-06-30$1.03bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-07-31, accession 0001082554-24-000035.Report this figure1,022Total liabilities, Q3 FY2024, at 2024-09-30$1.02bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-30, accession 0001082554-24-000047.Report this figure920Total liabilities, FY2024, at 2024-12-31$920.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-25, accession 0001082554-26-000006.Report this figure937Total liabilities, Q1 FY2025, at 2025-03-31$936.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure734Total liabilities, Q2 FY2025, at 2025-06-30$734.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure761Total liabilities, Q3 FY2025, at 2025-09-30$760.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure784Total liabilities, FY2025, at 2025-12-31$783.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure813Total liabilities, Q1 FY2026, at 2026-03-31$813.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure820Total liabilities, Q2 FY2026, at 2026-06-30$819.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure
Shareholders' equity$m5,712Shareholders' equity, Q3 FY2023, at 2023-09-30$5.71bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-30, accession 0001082554-24-000047.Report this figure5,985Shareholders' equity, FY2023, at 2023-12-31$5.98bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-25, accession 0001082554-26-000006.Report this figure5,338Shareholders' equity, Q1 FY2024, at 2024-03-31$5.34bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure5,697Shareholders' equity, Q2 FY2024, at 2024-06-30$5.70bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure6,101Shareholders' equity, Q3 FY2024, at 2024-09-30$6.10bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure6,444Shareholders' equity, FY2024, at 2024-12-31$6.44bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure6,807Shareholders' equity, Q1 FY2025, at 2025-03-31$6.81bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure7,174Shareholders' equity, Q2 FY2025, at 2025-06-30$7.17bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure6,590Shareholders' equity, Q3 FY2025, at 2025-09-30$6.59bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure7,096Shareholders' equity, FY2025, at 2025-12-31$7.10bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure5,901Shareholders' equity, Q1 FY2026, at 2026-03-31$5.90bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure6,400Shareholders' equity, Q2 FY2026, at 2026-06-30$6.40bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure

Cash flow

Operating cash flow$313.6m, Q2 FY2026
Capital expenditure$108.0m, Q2 FY2026
Share repurchases$0, Q2 FY2026
UNITED THERAPEUTICS Corp, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m346Operating cash flow, Q3 FY2023, three months to 2023-09-30$346.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-30, accession 0001082554-24-000047. Derived: 9-month figure less the 6-month figure.Report this figure151Operating cash flow, Q4 FY2023, three months to 2023-12-31$150.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure377Operating cash flow, Q1 FY2024, three months to 2024-03-31$376.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure232Operating cash flow, Q2 FY2024, three months to 2024-06-30$232.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-30, accession 0001628280-25-036541. Derived: 6-month figure less the 3-month figure.Report this figure377Operating cash flow, Q3 FY2024, three months to 2024-09-30$377.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-29, accession 0001082554-25-000034. Derived: 9-month figure less the 6-month figure.Report this figure341Operating cash flow, Q4 FY2024, three months to 2024-12-31$341.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure461Operating cash flow, Q1 FY2025, three months to 2025-03-31$461.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure192Operating cash flow, Q2 FY2025, three months to 2025-06-30$191.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001082554-26-000027. Derived: 6-month figure less the 3-month figure.Report this figure562Operating cash flow, Q3 FY2025, three months to 2025-09-30$562.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-29, accession 0001082554-25-000034. Derived: 9-month figure less the 6-month figure.Report this figure346Operating cash flow, Q4 FY2025, three months to 2025-12-31$346.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure463Operating cash flow, Q1 FY2026, three months to 2026-03-31$463.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure314Operating cash flow, Q2 FY2026, three months to 2026-06-30$313.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001082554-26-000027. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m65.7Capital expenditure, Q3 FY2023, three months to 2023-09-30$65.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-10-30, accession 0001082554-24-000047. Derived: 9-month figure less the 6-month figure.Report this figure78.7Capital expenditure, Q4 FY2023, three months to 2023-12-31$78.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure38.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$38.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure45.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$45.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-30, accession 0001628280-25-036541. Derived: 6-month figure less the 3-month figure.Report this figure76.5Capital expenditure, Q3 FY2024, three months to 2024-09-30$76.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-29, accession 0001082554-25-000034. Derived: 9-month figure less the 6-month figure.Report this figure86.7Capital expenditure, Q4 FY2024, three months to 2024-12-31$86.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure74.9Capital expenditure, Q1 FY2025, three months to 2025-03-31$74.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure62.2Capital expenditure, Q2 FY2025, three months to 2025-06-30$62.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001082554-26-000027. Derived: 6-month figure less the 3-month figure.Report this figure211Capital expenditure, Q3 FY2025, three months to 2025-09-30$210.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-29, accession 0001082554-25-000034. Derived: 9-month figure less the 6-month figure.Report this figure173Capital expenditure, Q4 FY2025, three months to 2025-12-31$172.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure101Capital expenditure, Q1 FY2026, three months to 2026-03-31$100.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure108Capital expenditure, Q2 FY2026, three months to 2026-06-30$108.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001082554-26-000027. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-10-30, accession 0001082554-24-000047. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure1,000Share repurchases, Q1 FY2024, three months to 2024-03-31$1.00bn. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure0.0Share repurchases, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-07-30, accession 0001628280-25-036541. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-29, accession 0001082554-25-000034. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure0.0Share repurchases, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-05, accession 0001082554-26-000027. Derived: 6-month figure less the 3-month figure.Report this figure1,000Share repurchases, Q3 FY2025, three months to 2025-09-30$1.00bn. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-10-29, accession 0001082554-25-000034. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-25, accession 0001082554-26-000006. Derived: 12-month figure less the 9-month figure.Report this figure1,500Share repurchases, Q1 FY2026, three months to 2026-03-31$1.50bn. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure0.0Share repurchases, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-05, accession 0001082554-26-000027. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)45.80m, Q2 FY2026
UNITED THERAPEUTICS Corp, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares48.7Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3048,700,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-01, accession 0001082554-23-000031.Report this figure49.6Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3149,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-01, accession 0001082554-24-000025.Report this figure49.5Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3049,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-07-31, accession 0001082554-24-000035.Report this figure49.7Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3049,700,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-30, accession 0001082554-24-000047.Report this figure49.7Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3149,700,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-04-30, accession 0001082554-25-000023.Report this figure47.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3047,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-30, accession 0001628280-25-036541.Report this figure48.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3048,400,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure48.6Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3148,600,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure48.3Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3048,300,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure47.3Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3047,300,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-29, accession 0001082554-25-000034.Report this figure47.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3147,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-06, accession 0001082554-26-000020.Report this figure45.8Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3045,800,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure

Shares outstanding: 42.89mShares outstanding, period not labelled, at 2026-07-2942,890,692 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001082554-26-000027.Report this figure at Jul 29, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. Listed shows no prices and gives no investment advice.